Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012 Jul 26:3:267.
doi: 10.3389/fmicb.2012.00267. eCollection 2012.

Species tropism of HIV-1 modulated by viral accessory proteins

Affiliations

Species tropism of HIV-1 modulated by viral accessory proteins

Masako Nomaguchi et al. Front Microbiol. .

Abstract

Human immunodeficiency virus type 1 (HIV-1) is tropic and pathogenic only for humans, and does not replicate in macaque monkeys routinely used for experimental infections. This specially narrow host range (species tropism) has impeded much the progress of HIV-1/acquired immunodeficiency syndrome (AIDS) basic research. Extensive studies on the underlying mechanism have revealed that Vif, one of viral accessory proteins, is critical for the HIV-1 species tropism in addition to Gag-capsid protein. Another auxiliary protein Vpu also has been demonstrated to affect this HIV-1 property. In this review, we focus on functional interactions of these HIV-1 proteins and species specific-restriction factors. In addition, we describe an evolutional viewpoint that is relevant to the species tropism of HIV-1 controlled by the accessory proteins.

Keywords: HIV-1; Vif; Vpu; accessory protein; species tropism.

PubMed Disclaimer

Figures

FIGURE 1
FIGURE 1
Genome organization of primate immunodeficiency viruses. Various proviral genomes are schematically shown. As indicated by colored boxes, the vpr and vpu genes of SIVcpz/HIV-1 came from those of SIVrcm and SIVmon/mus/gsn, respectively. Also, the vif genes of SIVcpz/HIV-1 originated from that of SIVrcm. In addition, as shown by colored boxes, HIV-1 nef gene is similar to but distinct from SIVcpz nef gene. HIV-1 nef gene is different from those of SIVmon/mus/gsn, SIVrcm, and HIV-2 as indicated. For virus designations, see text.
FIGURE 2
FIGURE 2
A schema of replication kinetics by HIV-1 wild-type and mutant viruses. Viral growth properties in cells are illustrated based on numerous infection experiments in our laboratory. WT, wild-type.
FIGURE 3
FIGURE 3
HIV-1 replication and APOBEC3G. On the basis of results reported so far, the action mechanism of Vif is depicted. Replication process for wild-type (WT) and ΔVif mutant viruses are schematically shown on the basis of previously reported review articles (Holmes et al., 2007; Huthoff and Towers, 2008; Strebel et al., 2009). A3G, APOBEC3G; IN, viral integrase protein.
FIGURE 4
FIGURE 4
HIV-1 replication and Tetherin. On the basis of results reported so far, the action mechanism of Vpu is depicted. Replication process for wild-type (WT) and ΔVpu mutant viruses are schematically shown on the basis of previously reported review articles (Tokarev et al., 2009; Douglas et al., 2010; Evans et al., 2010). TGN, trans-Golgi network.

References

    1. Arias J. F., Iwabu Y., Tokunaga K. (2011). Structural basis for the antiviral activity of BST-2/tetherin and its viral antagonism. Front. Microbiol. 2:250. 10.3389/fmicb.2011.00250 - DOI - PMC - PubMed
    1. Berger G., Durand S., Fargier G., Nguyen X.-N., Cordeil S., Bouaziz S., Muriaux D., Darlix J.-L., Cimarelli A. (2011). APOBEC3A is a specific inhibitor of the early phases of HIV-1 infection in myeloid cells. PLoS Pathog. 7 e1002221 10.1371/journal.ppat.1002221 - DOI - PMC - PubMed
    1. Doi N., Fujiwara S., Adachi A., Nomaguchi M. (2011). Rhesus M1.3S cells suitable for biological evaluation of macaque-tropic HIV/SIV clones. Front. Microbiol. 2:115. 10.3389/fmicb.2011.00115 - DOI - PMC - PubMed
    1. Dorfman T., Gottlinger H. G. (1996). The human immunodeficiency virus type 1 capsid p2 domain confers sensitivity to the cyclophilin-binding drug SDZ NIM 811. J. Virol. 70 5751–5757 - PMC - PubMed
    1. Douglas J. L., Gustin J. K., Viswanathan K., Mansouri M., Moses A. V., Fruh K. (2010). The great escape: viral strategies to counter BST-2/tetherin. PLoS Pathog. 6 e1000913 10.1371/journal.ppat.1000913 - DOI - PMC - PubMed

LinkOut - more resources